500660:BOM
GlaxoSmithKline Pharmaceuticals Ltd
₹2.567,25
arrow_upward
+1,75%(+44,25) 1D
16 ຕ.ລ., 15 ໂມງ 30 ນາທີ 00 ວິນາທີ GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 500660...
Open
₹2.527,25
High
₹2.572,40
Low
₹2.527,25
Mkt. cap
434,57 ຕື້
Avg. vol.
5,03 ພັນ
Volume
2,37 ພັນ
Dividend
2,22%
Quarterly dividend
₹14,25
Ex-dividend date
29 ພ.ພ. 2026
P/E ratio
40,72
52-wk high
₹3.121,10
52-wk low
₹2.088,00
EPS
₹63,05
Shares outstanding
169,41 ລ້ານ
No. of employees
3 ພັນ
Open
₹2.527,25
High
₹2.572,40
Low
₹2.527,25
Mkt. cap
434,57 ຕື້
Avg. vol.
5,03 ພັນ
Volume
2,37 ພັນ
Dividend
2,22%
Quarterly dividend
₹14,25
Ex-dividend date
29 ພ.ພ. 2026
P/E ratio
40,72
52-wk high
₹3.121,10
52-wk low
₹2.088,00
EPS
₹63,05
Shares outstanding
169,41 ລ້ານ
No. of employees
3 ພັນ
News stories
From web sources and news partners
Simply Wall Street
·
25 ນາທີກ່ອນ
What AAON Bears Saw Before The Fall
Trefis
·
26 ນາທີກ່ອນ
1 S&P 500 Stock Hit A 52-Week Low On Friday
MarketBeat
·
29 ນາທີກ່ອນ
iHeartMedia (NASDAQ:IHRT) Stock Price Down 7.3% - Should You Sell?
MarketWatch
·
8 ຊົ່ວໂມງກ່ອນ
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees3,1 ພັນ
Founded13 ພ.ຈ. 1924
Headquarters-
SectorPharmaceutical industry
Websiteindia-pharma.gsk.com